tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

GNNSF Stock Latest News

Legend Biotech Reports Strong CARVYKTI® Sales for Q4 2024
Company AnnouncementsLegend Biotech Reports Strong CARVYKTI® Sales for Q4 2024
9d ago
Genscript Biotech Boosts Stake in Probio Cayman
PremiumCompany Announcements
Genscript Biotech Boosts Stake in Probio Cayman
1M ago
Genscript Biotech’s CARVYKTI® Boosts Multiple Myeloma Results
PremiumCompany Announcements
Genscript Biotech’s CARVYKTI® Boosts Multiple Myeloma Results
2M ago
Genscript Biotech Announces CEO Resignation and Leadership Changes
PremiumCompany Announcements
Genscript Biotech Announces CEO Resignation and Leadership Changes
2M ago
Genscript Biotech Aligns Interests with Restricted Share Grant
PremiumCompany Announcements
Genscript Biotech Aligns Interests with Restricted Share Grant
2M ago
Genscript Biotech Strikes Lucrative Licensing Deal
PremiumCompany AnnouncementsGenscript Biotech Strikes Lucrative Licensing Deal
3M ago
Genscript Biotech Strengthens Board with New Appointment
Premium
Company Announcements
Genscript Biotech Strengthens Board with New Appointment
3M ago
Genscript Biotech Reveals Board Composition and Strategy
Premium
Company Announcements
Genscript Biotech Reveals Board Composition and Strategy
3M ago
Genscript Reports on Legend Biotech’s Q3 Financials
PremiumCompany Announcements
Genscript Reports on Legend Biotech’s Q3 Financials
3M ago
Genscript Biotech’s CARVYKTI Shows Promise in Myeloma Treatment
PremiumCompany Announcements
Genscript Biotech’s CARVYKTI Shows Promise in Myeloma Treatment
3M ago
Genscript Biotech Announces Deconsolidation of Legend Biotech
PremiumCompany Announcements
Genscript Biotech Announces Deconsolidation of Legend Biotech
3M ago
Genscript Biotech Reports Strong CARVYKTI® Sales Growth
PremiumCompany Announcements
Genscript Biotech Reports Strong CARVYKTI® Sales Growth
4M ago
Genscript’s Breakthrough in Multiple Myeloma Treatment
PremiumCompany AnnouncementsGenscript’s Breakthrough in Multiple Myeloma Treatment
4M ago
Genscript Biotech Announces Subsidiary’s AGM Date
Premium
Company Announcements
Genscript Biotech Announces Subsidiary’s AGM Date
4M ago
Genscript Biotech Welcomes New Directors
Premium
Company Announcements
Genscript Biotech Welcomes New Directors
5M ago
Genscript Biotech Reveals Board Structure
PremiumCompany Announcements
Genscript Biotech Reveals Board Structure
5M ago
Legend Biotech announces cilta-cel approval in China for multiple myeloma
PremiumThe Fly
Legend Biotech announces cilta-cel approval in China for multiple myeloma
5M ago
LEGN
Genscript Biotech’s New Drug Approval Sparks Interest
PremiumCompany Announcements
Genscript Biotech’s New Drug Approval Sparks Interest
5M ago
Genscript Biotech Awards Shares to Employees
PremiumCompany Announcements
Genscript Biotech Awards Shares to Employees
5M ago
Genscript Biotech’s H1 2024 Financial Surge
PremiumCompany AnnouncementsGenscript Biotech’s H1 2024 Financial Surge
6M ago
Genscript Biotech Reports Mid-Year Financials
Premium
Company Announcements
Genscript Biotech Reports Mid-Year Financials
6M ago
Genscript Biotech Plans Key Mid-Year Meeting
Premium
Company Announcements
Genscript Biotech Plans Key Mid-Year Meeting
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >